Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,479 across all filing types
Latest filing 2022-05-05 Earnings Release
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Earnings Release 2022
Earnings Release Classification · 1% confidence The document is titled 'Coloplast A/S - Selskabsmeddelelse nr. 04/2022 - Regnskabsmeddelelse, H1 2021/22' and contains detailed financial results for the first half (H1) of the fiscal year (1. oktober 2020 – 31. marts 2021). It includes key metrics like organic growth, revenue, operating profit, EPS, and guidance updates. This content structure strongly indicates a comprehensive financial report for a period shorter than a year. This aligns perfectly with the definition of an Interim / Quarterly Report (Code: IR). Although it is a 'Regnskabsmeddelelse' (Financial Announcement), its depth and coverage of the half-year period make it more than just a brief Earnings Release (ER). The presence of an attached file link and the overall format suggest it is the primary release of the interim results, not just an announcement of the release itself. H1 2022
2022-05-05 Danish
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive interim financial report for Coloplast A/S covering the H1 2021/22 period (1 October 2021 - 31 March 2022). It contains detailed financial statements, income statement data, balance sheet information, cash flow analysis, and management commentary on strategic priorities and business performance. It is not a mere announcement or certification, but the substantive financial report itself, fitting the definition of an Interim/Quarterly Report. H1 2021
2022-05-05 English
Coloplast A/S - Announcement no. 04/2022 – Interim Financial Report, H1 2021/22
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive financial report for the first half (H1) of the 2021/22 fiscal year for Coloplast A/S. It contains detailed financial statements, key performance indicators (KPIs), management commentary on business trends, and strategic updates. It is not an announcement of a report (RPA) because it contains the actual financial data and analysis. It is not a full Annual Report (10-K) as it covers only a six-month interim period. Therefore, it is classified as an Interim/Quarterly Report. H1 2021
2022-05-05 Danish
Coloplast A/S - Announcement no. 04/2022 – Interim Financial Report, H1 2021/22
Earnings Release Classification · 1% confidence The document is titled 'Interim Financial Report, H1 2021/22' and provides a detailed summary of financial performance, including revenue, EBIT, and guidance updates for the period. While it mentions an attachment at the end, the text itself contains the core financial data and management commentary typical of an interim report. Therefore, it is classified as an Interim/Quarterly Report (IR). H1 2022
2022-05-05 English
Transaction in Own Shares 2022
Transaction in Own Shares Classification · 1% confidence The document title explicitly states: "Transaction data in relation to Coloplast's share buy-back programme, week 16 (programme completed)". The content details specific dates, volumes, and prices of share transactions executed by the company, referencing MAR and Safe Harbour Regulations. This directly corresponds to the definition of a report detailing the company buying back or selling its own shares, which is classified as 'Transaction in Own Shares' (POS). The document is a detailed report of transactions, not an announcement of a report's publication.
2022-04-25 English
Transaction in Own Shares 2022
Transaction in Own Shares Classification · 1% confidence The document title is "Coloplast A/S - Transaktioner i henhold til aktietilbagekøbsprogram, uge 16 (program afsluttet)" which translates to "Coloplast A/S - Transactions pursuant to share buyback program, week 16 (program concluded)". The text details specific transactions (number of shares bought, average price, total value) related to a share buyback program and confirms the program's conclusion. This activity directly relates to the company managing its own shares, which corresponds to the definition of 'Transaction in Own Shares'. The code for this is POS. Although it is a detailed report of transactions, it is not a general regulatory filing (RNS) or an announcement of a report (RPA), but the report itself detailing the share repurchase activity.
2022-04-25 Danish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.